Denoted on the table (*), patient 10 had a lower percentage of CD4 and CD8 positive cells from baseline tumour samples compared to the selected responding patients (Pt 2, 11, 13, 15), potentially indicating a difference in the immune profile or immune activity in that case. This evidence concerns the gene CD8A and neoplasm.